Traditional Chinese medicine cooperative therapy for patients with Bladder Cancer after operation: a randomized controlled trial

Not Applicable

• Conditions: Bladder cancer

• Registration Number: ITMCTR2000003021
• Lead Sponsor: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

1. In line with transurethral resection of bladder tumor (TURPBT), and pathological diagnosis of malignant tumors;
2. The Karnofsky Performance Status (KPS) score >60 points, and the expected survival period >1 year;
3. Aged 25 to 80 years;
4. Those who have voluntarily signed an informed consent form.

Exclusion Criteria

1. Allergic constitution and those who are allergic to experimental drugs;
2. Patients with renal cancer, bladder tuberculosis, and urinary calculi;
3. Combined with other malignant tumor patients;
4. Patients with blood system diseases, coagulopathy and autoimmune diseases;
5. Combined with severe cardiovascular disease, cerebrovascular disease, hematopoietic system disease, neuropathic patients;
6. Participated in other clinical researchers 3 months before the trial;
7. Non-resection of bladder tumors.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tumor patient Karnofsky Performance Status;

Secondary Outcome Measures

Name	Time	Method
Bladder cancer syndrome score;